AQR Capital Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
OM
KCM
AQR Capital Management's GOSS Position: Q3 2026 in Review
AQR Capital Management reduced its Gossamer Bio (GOSS) stake by 93% in Q3 2026, selling an estimated $2.35M and leaving 13,974 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #3920.
AQR Capital Management first reported a position in GOSS in Q4 2022 and has held it in 6 quarters since. The position peaked at $3.47M in Q4 2025. 76 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.
- AQR Capital Management held 13,974 shares of Gossamer Bio worth $166K as of Q3 2026.
- AQR Capital Management sold 181,401 Gossamer Bio shares in Q3 2026, an estimated $2.35M.
- Gossamer Bio made up ﹤0.01% of AQR Capital Management's portfolio in Q3 2026, its #3920 holding.
- AQR Capital Management first reported a position in Gossamer Bio in Q4 2022 and has held it in 6 quarters since.
- AQR Capital Management's Gossamer Bio position peaked at $3.47M in Q4 2025.
- 76 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.
Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.